MEGAN RODGERS TSCHANNEN: Open Payments
NPI 1255071627 · BROOKFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 18 payments from 9 companies in 2025. Trend: 2023 $1,279 · 2024 $390 · 2025 $423
Food & beverage: $312Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $137 |
| Vanda Pharmaceuticals Inc. | 3 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
| Viatris Specialty LLC | 1 | $23 |
| ABBVIE INC. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
| PFIZER INC. | 1 | $14 |
Products named: FANAPT, REXULTI, CAPLYTA, SPRAVATO, YUPELRI, VRAYLAR, COBENFY, PAXLOVID.
Industry payments across MO — which companies pay providers there.
